Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IDOL (Inducible Degrader Of the LDL receptor) is an E3 ubiquitin ligase that plays a central role in the post-translational regulation of lipid metabolism and neuronal function. It is encoded by the *MYLIP* gene and is best known for targeting members of the low-density lipoprotein receptor (LDLR) family for degradation, thereby modulating cholesterol uptake and homeostasis. Expression of IDOL is directly regulated by liver X receptors (LXRs), which are nuclear receptors activated in response to increased cellular sterol levels.
IDOL mediates ubiquitination and subsequent lysosomal degradation of LDLR, VLDLR, and ApoER2, thereby reducing cholesterol uptake.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin ligase IDOL.